-
-
-
-
-
-
-
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results
-
-
-
-
-
-
-
ImmunoCellular Therapeutics (IMUC) Prices Offering of Convertible Preferred Stock and Warrants
-
-
-
-
-
-
-
ImmunoCellular Therapeutics (IMUC) Prices 47M Share Stock Offering for Proceeds of $7.4M
-
-
-
-
-
-
-
Pre-Open Stock Movers 9/24: (LPCN) (MACK) (ACOR) Higher; (ECTE) (ATOS) (GTI) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/26: (SPCB) (TWTR) (TSLA) Higher; (ORMP) (IGLD) (BBRY) Lower (more...)
-
-
-
-
-
-
1,161,868 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

